Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004
Multiple Cerebral Aneurysms in Factor VII Deficiency
AJNR 25:784-786, Schilling,A.M.,et al, 2004
Clopidogrel-Associated TTP, An Update of Pharmacovigilance Efforts
Stroke 35:533-538, Zakarija,A.,et al, 2004
Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004
Benefit of Clopidogrel Over Aspirin is Amplified in Patients with a History of Ischemic Events
Stroke 35:528-532, Ringleb,P.A.,et al, 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke:The GIFA Study
Stroke 35:913-917, Volpato,S.,et al, 2004
Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Pract Neurology 4:50-55, Razvi,S.S.M. &Muir,K.W., 2004
Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003
Mutations in the Molybdenum Cofactor Biosynthetic Genes MOCS1, MOCS2, and GEPH
Hum Mutat 21:569-576, Reiss,J. &Johnson,J.L., 2003
10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003
Risks and Benefits of Anticoagulant and Antiplatelet Medication Use Before Cataract Surgery
Ophthalmology 110:1784-1788, Katz,J.,et al, 2003
Stroke
Lancet 362:1211-1224, Warlow,C.,et al, 2003
Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Mayo Clin Proc 78:1392-1396, Otley,C.C., 2003
Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage, A Systematic Review
Stroke 34:2285-2289, Mees,S.M.D.,et al, 2003
Antifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage, A Major Update of a Cochrane Review
Stroke 34:2308-2309, Roos,Y.,et al, 2003
Should I Start All My Ischaemic Stroke and TIA Patients on a Statin, an ACE Inhibitor, a Diuretic, and Aspirin Today?
JNNP 74:1461-1464, Sandercock,P.A.G., 2003
Diagnostic Approach in Patients with Symmetric Imaging Lesions of the Deep Gray Nuclei
The Neurologist 9:250-261, Finelli,P.F.&DiMario,Jr,F.J., 2003
Dietary Antioxidants and the Risk of Ischemic Stroke
Neurol 61:1273-1275, Voko,Z.,et al, 2003
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003
Brain MR Imaging in Acute Hyperammonemic Encephalopathy Arising from Late-Onset Ornithine Transcarbamylase Deficiency
AJNR 24:390-393, Takanashi,J-i.,et al, 2003
Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003
Rapidly Reversible Dementia
Lancet 361:392, Bernstein,R.,et al, 2003
Anticoagulants Versus Antiplatelet Agents for Acute Ischemic Stroke
Stroke 34:1571-1572, Berge,E. &Sandercock,P., 2003
Asymptomatic Microbleeds as a Risk Factor for Aspirin-Associated Intracerebral Hemorrhages
Neurol 60:511-513, Wong,K.S.,et al, 2003
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003
Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Stroke 34:849-855, Grau,A.J.,et al, 2003
Homocysteine, Silent Brain Infarcts, and White Matter Lesions: The Rotterdam Scan Study
Ann Neurol 51:285-289,279, Vermeer,S.E.,et al, 2002
Prognostic Significance of Uric Acid Serum Concentration in Patients with Acute Ischemic Stroke
Stroke 33:1048-1052, Chamorro,A.,et al, 2002
Diffusion-Weighted Imaging Abnormalities in Wernicke Encephalopathy
Arch Neurol 59:123-127, Chu,K.,et al, 2002
Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002
Aspirin Should be First-Line Antiplatelet Therapy in the Secondary Prevention of Stroke
Stroke 33:2137-2139, Warlow,C., 2002
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002
Out of Africa, Trypanosomiasis
NEJM 347:749-753, Sahlas,D.J.,et al, 2002
Neurological Presentation of Fabry's Disease in a 52 Year Old Man
JNNP 73:340-342, Mohanraj,R.,et al, 2002
MR Changes after Acute Cyanide Intoxication
AJNR 23:1398-1401, Rachinger,J.,et al, 2002
New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002
Prospective Assessment of Risk Factors for Recurrent Stroke During Childhood--A 5-year Follow-up Study
Lancet 360:1540-1545,1526, Strater,R.,et al, 2002
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
JAMA 288:2441-2448, van Walraven,C.,et al, 2002
Transient Ischemic Attack
NEJM 347:1687-1692, Johnston,S.C., 2002
Tinzaparin in Acute Ischaemic Stroke (TAIST):A Randomised Aspirin-Controlled Trial
Lancet 358:702-710,683, Bath,P.M.W.,et al, 2001
Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency
Arch Int Med 161:1534-1541, Hvas,A.,et al, 2001
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001
Combination Therapy With Clopidogrel and Aspirin
Stroke 32:2948-2949, Albers,G.W. &Amerenco,P., 2001
Cystic Fibrosis Presenting With Intracerebral Haemorrhage
Lancet 358:1960, Merelle,M.E.,et al, 2001
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001